Italy's NHS approved VAZKEPA® for reimbursement, enhancing access for high-risk cardiovascular patients in Europe.Quiver AI SummaryAmarin Corporation has announced that the Italian National Health Service...
Amarin Corporation appoints Peter Fishman as Chief Financial Officer, effective immediately, to lead global finance operations.Quiver AI SummaryAmarin Corporation has appointed Peter Fishman as Chief Financial...
Amarin Corporation plc AMRN reported an adjusted loss of 5 cents per share for the third quarter of 2024, which was in line with the Zacks Consensus Estimate. The company had reported breakeven earnings...
AMRN earnings call for the period ending September 30, 2024.
AMRN earnings call for the period ending June 30, 2024.
AMRN earnings call for the period ending March 31, 2024.